Regulation And Legal
Jubilant Generics Tax Adjustment Reduced to ₹42.41 Cr
Jubilant Pharmova discloses a rectification order for subsidiary Jubilant Generics reducing tax adjustments from ₹107.89 cr to ₹42.41 cr for AY 2023-24.
The order restores tax losses of ₹65.48 cr for
